Summary: The radioimmunoassay available from Behringwerke for pregnancy-specific ft-glycoprotein (S?i) was tested for its ability to detect pregnancy prior to the first missed menstrual period. It was found that the equine serum, used as solvent for the standards, did not react like human serum.
Introduction
associated plasma protein C. S?! is a glycoprotein, conThere is a rapidly growing interest in placental proteins taining about 28% carbohydrate. It has a molecular (1). One of the most recently discovered is the so called weight of 90,000 daltons. Immunological heterogeneity pregnancy*pecific ft .glycoprotein (SP t or PSßG), also has been described (2) . It is produced by the syncytiocaUed trophoblast-specific ft -globulin, or pregnancy trophoblast of the placenta and secreted in the maternal 0340-076X/81/0019-1197S02.00 © by Walter de Gruyter & Co.
-Berlin · New York (intervillous) circulation. during gestation (3) .
levels increase rapidly
The physiological function of SPj is not yet known, but it has been shown to have immunosuppressive activity. It may therefore play a part in preventing the rejection of the developing blastocyst (4) .
Trophoblastic tumours and some other neoplasms can produce SPj (5). The evidence concerning the presence of S?i in the serum of healthy men and non-pregnant women is conflicting (6) (7) (8) (9) .
In a study concerning the incidence of occult abortion a very sensitive indicator of pregnancy was needed.
Measurements of human chorionic gonadotropin were not taken into consideration because some of the patients had been treated with this hormone to induce ovulation. The aim of this present study was to test the suitability of the Behring S?i reagents.
Results

Assay characteristics
The 
Materials and Methods
Blood was collected from healthy men and non-pregnant women, and from pregnant women some of which had conceived after ovulation induction. Venous blood was drawn, allowed-to clot at room temperature and centrifuged for 10 min at 1,600^. The serum was decanted and stored in fractions at -18 °C.
Radioimmunoassay of SPi Serum levels of SPi were measured in a double-antibody radjoimmunoassay. Reagents were supplied by Behringwerke .
(Marburg/Lahn, GFR).
125
ilabeled-SP 1 , specific activity about 1.48 × 10 12 Bq/g (40 mCi/mg), was used without further purification. SPi standards (n° OTIL 02/03) were dissolved in equine serum in the range 0-360 Mg/1, Standards or sera were diluted with 0.1 mol/1 phosphate buffer (pH 7.4), containing 0.05 mol/1 ethylenediaminetetraacetic acid (EDTA) and bovine serum albumin (50 g/1). Equine serum A was obtained from the Rijksinstituut voor de Volksgezondheid, Bilthoven, the Netherlands, and bovine serum albumin (fraction V, A 8022) from Sigma (USA).
The assay conditions were as follows: tracer about 1.85 × 10 6 Bq (50 nCi) in 200 ìÀ was added to 100 ìÀ of serum in polystyrene tubes, 200 ìÀ anti-SPj antiserum was then added and incubated at room temperature for 16-24 h. Radioactivity bound to the antibody was precipitated with 100 ìÀ of sheep antirabbit ^-globulin serum using an incubation time of 1.5-4 h, followed by centrifugation for 15 min at 1,400#. The supernatant was decanted and aspirated off and the precipitates were counted for 2 min in a PW 4580 Automatic Gamma Analyser (Philips, Eindhoven, The Netherlands). We call this the "equilibrium" procedure. All counts were corrected by subtracting blank values from incubations where the anti-S?!-antiserum was replaced by buffer. In a modified, sequential assay technique, the incubation was started with anti-SP r antiserum and serum samples. After 16-24 h the tracer was added and a second incubation of 16-24 h followed. Precipitation was performed as described above. In the "equilibrium" incubation procedure the logitlog calibration curves were linear with a slope of -1.03 ± 0.13 (S.D.). Blank values were low, never exceeding a fraction of 0.02 of B 0 . Binding capacity for S?! was further evaluated in Scatchard plots. Since the binding was not complete after 24 h, a five days incubation at room temperature was carried out. Scatchard plots were not linear, indicating heterogeneity of the antibody ( fig. 3 ).
Following the method described by Sch nesh fer (10) and assuming two binding components, association constants (K) and antibody concentrations (Ab) were calculated K! = 81 X 10"* K 2 = 7 × ÉÏ' 2 I/jug SPj Abi =1.6 Ab 2 =2.0
The sequential procedure. gave a more sensitive assay. Performance of both procedures at 4 °C produced no improvement in the results.
The intra-assay reproducibility of both assay procedures is shown in table 2. The more sensitive procedure of sequential incubation leads to a better reproducibility for low SPx levels.
Effects of different standard solvents
Using the standard procedure, sera of healthy men and non-pregnant women were analysed. Almost all B/Bo values were greater than 1.00, leading to "negative" SPv alues. This could be explained by assuming that the standards dissolved in equine serum contained a material reacting like SPj in this assay. This was further elucidated by testing standards in different media.
Standards were prepared in the concentration range 5.6-360 ì §/1, in the following media:
Bovine serum albumin 50 g/1 in water, pooled human male serum and in equine serum. Dilutions of sera were made up in the same media.
The dose response curves parallel those of the original curves (fig. 4) .
The bovine serum albumin solvent gave the highest fraction of zero binding. Values of about 10 ìg/l were found for the equine serum and from 5-10 ìg/l for the male serum, when read on a standard curve in bovine serum albumin.
Using the sequential incubation technique, the differences were up to 5
On the basis of these findings it seemed justified to abandon the equine serum, and to replace it with albumin and human male serum as a standard solvent.
Levels ofSPi in non-pregnant subjects
The sera of 22 men and non-pregnant women were analysed, by equilibrium and sequential incubation procedures. The minimal detectable dose (MDD), defined as the dose at a distance of two standard deviations from the mean B 0 (n = 20) was estimated. The results are presented in table 3.
The non-pregnant values found, using the standards in albumin and following the equilibrium procedure, seemed rather high, when compared with values in the literature (6-9).
Estimation of SPj in the same subjects by the sequential incubation procedure, resulted in lower values. Possibly the sequential incubation procedure also leads to a more specific SPj estimation, although the values found still differ significantly from zero.
The same effect was not noticed using standards in human male serum. 
Discussion
Detection of a pregnancy-specific substance in the earliest possible phase of pregnancy requires a very sensitive and specific assay. In its original form the Behring-kit was not suitable for this purpose, so we tried to modify the procedure. Systematic differences in the assay of up to 10 jug/1 indicated the importance of the standard medium. The original standards in equine serum were therefore replaced by standards in albumin and in pooled human male serum.
' With the former method a SPj-like substance was found in sera of men and non-pregnant women. Further studies are required to reveal the nature and origin of this "SP^', Of course matrix effects could play a role, although one cannot exclude the presence of cross reacting material. It is also possible that the heterogeneity, detected in the antibody, plays a role or that purification of the tracer may lead to a reduction of the cross reaction.
Our experience with the different standard diluents perhaps gives an indication why some authors do find a detectable amount of SP l in non-pregnant sera, while others do not. In our opinion the "positive" value of 1.7 Mg/1 found by Seppälä (11) ten days after AID (Artificial Insemination Donor) could fall within the non-pregnant range. In an ongoing study with sera of pregnant women there is evidence that SPi increments above the upper limit of non-pregnant values are seen 14-17 days after ovulation. Thereafter the levels increase exponentially to values of 300-400 g/l within one week (data to be published).
The sequential procedure is so sensitive that it seems useful only for a few days after the detection of S^ -levels above the non-pregnant values.
Using the equilibrium procedure, with standards in pooled human male serum, values above 3 g/l indicate pregnancy, whereas the corresponding value for the modified sequential procedure is 1 /ig/1. Because of the minimal detectable dose in the latter case the cut-off value lies at 1.5 g/l. Perhaps it is possible to detect pregnancy very early in a longitudinal, series of SPi -determinations, by detecting an increase in SP l . In that case the assay must be optimal in the low SP t -region. A sequential assay seems to fulfill this requirement best.
